In the global phase 3 polarisDMD trial for edasalonexent, standardized outcome measure training produces excellent test-retest variability in NSAA

Eagle, M; MacDougall, J; Mancini, M; Donovan, J

NEUROMUSCULAR DISORDERS, 2020; 30 (): S130